Decreased HLA-C1 alleles in couples of KIR2DL2 positive women with recurrent pregnancy loss

J Reprod Immunol. 2020 Nov:142:103186. doi: 10.1016/j.jri.2020.103186. Epub 2020 Aug 13.

Abstract

Specific killer cell immunoglobulin-like receptor (KIR) in women with recurrent pregnancy loss (RPL) and HLA ligands in couples invoke a susceptibility to RPL. However, the relationship between KIR2DL2 and its cognate ligand HLA-C1 has not been explored. In this prospective cohort study, 160 Caucasian women with RPL and 99 partners were included. KIR/HLA-C typing, NK assay, Th1/Th2 intracellular cytokine ratios, 25-(OH)-vitamin D level, and the presence of autoantibodies were analyzed. KIR2DL2 positive women (P = 0.023) and their partners (P = 0.017) had lower allele frequencies of HLA-C1 than those of KIR2DL2 negative women. KIR2DL2 positive women had significantly lower genotype frequency of HLA-C1C1 as compared to the North American Caucasian population controls (P < 0.05). In the partners of KIR2DL2 positive women, there was a substantially higher frequency of HLA-C2C2 than controls (P = 0.016). Besides, KIR2DL2 negative women had a higher prevalence of anti-ssDNA antibody as compared with that of KIR2DL2 positive women (P = 0.043). There were no differences in the distribution of HLA-C genotypes based on KIR2DL2, regardless of pregnancy outcome in women with RPL and their partners while on immunomodulation treatment. In conclusion, decreased ligands for inhibitory KIRs (inhKIR) could lead to insufficient inhibition of maternal uterine NK cells toward the trophoblast, thereby contributing to the pathogenesis of RPL. Specific KIR and HLA-C genotyping may predict the reproductive outcome of women with RPL.

Keywords: HLA-C; KIR2DL2; Natural killer cells; Recurrent pregnancy loss.

Publication types

  • Observational Study

MeSH terms

  • Abortion, Habitual / blood
  • Abortion, Habitual / genetics*
  • Abortion, Habitual / immunology
  • Abortion, Habitual / prevention & control
  • Adult
  • Alleles
  • Autoantibodies / blood
  • Autoantibodies / immunology
  • Case-Control Studies
  • DNA, Single-Stranded / immunology
  • Female
  • Gene Frequency / immunology
  • Genetic Predisposition to Disease*
  • HLA-C Antigens / genetics*
  • HLA-C Antigens / metabolism
  • Humans
  • Immunologic Factors / administration & dosage*
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism
  • Male
  • Pregnancy
  • Pregnancy Outcome
  • Prospective Studies
  • Receptors, KIR2DL2 / analysis
  • Receptors, KIR2DL2 / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Signal Transduction / immunology
  • Treatment Outcome

Substances

  • Autoantibodies
  • DNA, Single-Stranded
  • HLA-C Antigens
  • Immunologic Factors
  • KIR2DL2 protein, human
  • Receptors, KIR2DL2